
    Original Text: White blood cells (WBC) > 3 x 10^9/L (unless due to bone marrow infiltration by tumor, in which case WBC > 2 x 10^9/L is allowed) (within 7 days prior to treatment registration)
    Disease/Condition: Leukocytosis
    Procedure: none
    Drug: none
    Biomarker: none
    Computable Rule: WBC > 3*10^9 AND NOT BM_INFILTRATION_BY_TUMOR == True

Criterion:
    Patients with a history of myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), or other myeloproliferative disorders should be excluded from this study.

Output:
    Original Text: Patients with a history of myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), or other myeloproliferative disorders should be excluded from this study.
